Cell-derived Matrix Assays to Assess Extracellular Matrix Architecture and Track Cell Movement
The extracellular matrix (ECM) is a non-cellular network of macromolecules, which provides cells and tissues with structural support and biomechanical feedback to regulate cellular function, tissue tension, and homeostasis. Even subtle changes to ECM abundance, architecture, and organization can affect downstream biological pathways, thereby influencing normal cell and tissue function and also driving disease conditions. For example, in cancer, the ECM is well known to provide both biophysical and biochemical cues that influence cancer initiation, progression, and metastasis, highlighting the need to better understand cell–ECM interactions in cancer and other ECM-enriched diseases. Initial cell-derived matrix (CDM) models were used as an in vitro system to mimic and assess the physiologically relevant three-dimensional (3D) cell–ECM interactions. Here, we describe an expansion to these initial CDM models generated by fibroblasts to assess the effect of genetic or pharmacological intervention on fibroblast-mediated matrix production and organization. Additionally, we highlight current methodologies to quantify changes in the ultrastructure and isotropy of the resulting ECM and also provide protocols for assessing cancer cell interaction with CDMs. Understanding the nature and influence of these complex and heterogeneous processes can offer insights into the biomechanical and biochemical mechanisms, which drive cancer development and metastasis, and how we can target them to improve cancer outcomes.
Bone-in-culture Array to Model Bone Metastasis in ex vivo Condition
Calvarial Bone Implantation and in vivo Imaging of Tumor Cells in Mice
3D Stroma Invasion Assay
Analysis of Cancer Stromal Reaction Using an O-ring Co-culture Assay
3D Gel Invasion Assay of Gastric Cancer Cells with Fibroblasts
In vivo Lineage-tracing Studies in a Cancer Stem Cell Population in Neuroblastoma
Isolation and Immortalization of Fibroblasts from Different Tumoral Stages